In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

Merck & Co. is putting down $30 million upfront to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset designed to take on the tough-to-treat brain cancer glioblastoma (GBM).

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

they may also be wise - along with anybody searching for short-term value or a decent entry point to open a position in Merck stock - to pay close attention to the R&D updates during the Q3 ...

International science and technology firm Merck has announced investment of over £4 million in its Life Science facility in Livingston, bringing new jobs to the town. Did you know with a Digital ...

Gilead Sciences and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to sustained suppression of the virus out to 48 weeks in a ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

In a 14-1 vote, the panel moved to expand its usage recommendation for both Pfizer’s Prevnar 20 and Merck’s Capvaxive to include all adults aged 50 and older as well as adults between 19 and ...

Shares of Microsoft and Merck are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and ...

(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of ...

Shares of Microsoft and Merck are trading lower Thursday morning, sending the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and FactSet ...